Rituximab-Associated Inflammatory Progressive Multifocal Leukoencephalopathy
Progressive multifocal leukoencephalopathy (PML) is a rare disease of the immunosuppression that results from neurotropic invasion of the JC virus which leads to demyelination of oligodendrocytes. Immune reconstitution inflammatory syndrome (IRIS), on the other hand, is a condition of inflammation t...
Saved in:
Main Authors: | Chandra Punch, Christina Schofield, Penelope Harris |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2016/8915047 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebellar Involvement in an Immunocompetent Patient Presenting with Progressive Multifocal Leukoencephalopathy
by: Rafael Garcia-Carretero, et al.
Published: (2017-01-01) -
Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod
by: Tim Sinnecker, et al.
Published: (2016-01-01) -
Early Magnetic Resonance Detection of Natalizumab-Related Progressive Multifocal Leukoencephalopathy in a Patient with Multiple Sclerosis
by: Guglielmo Manenti, et al.
Published: (2013-01-01) -
Sintilimab for treating progressive multifocal leukoencephalopathy caused by human polyomavirus 2 virus infection following allogeneic hematopoietic cell transplantation: a case report
by: Xuelian Jin, et al.
Published: (2025-12-01) -
JC Virus PCR Detection Is Not Infallible: A Fulminant Case of Progressive Multifocal Leukoencephalopathy with False-Negative Cerebrospinal Fluid Studies despite Progressive Clinical Course and Radiological Findings
by: Mohamed-Ali Babi, et al.
Published: (2015-01-01)